resveratrol has been researched along with Allodynia in 36 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 4 (11.11) | 29.6817 |
| 2010's | 22 (61.11) | 24.3611 |
| 2020's | 10 (27.78) | 2.80 |
| Authors | Studies |
|---|---|
| Cordaro, M; Crupi, R; Cuzzocrea, S; D'Amico, R; Di Paola, R; Fusco, R; Genovese, T; Gugliandolo, E; Impellizzeri, D; Peritore, AF; Siracusa, R | 1 |
| He, XH; Li, YD; Liu, CC; Shen, KF; Wang, J; Wu, W; Xu, LJ | 1 |
| Han, Y; Lu, Y; Xu, HM; Zhang, YL | 1 |
| Ding, J; Hao, M; Li, M; Li, Y; Tang, Q; Wang, B; Xie, M; Zhu, H | 1 |
| Dagostino, C; Fini, M; Giancotti, LA; Gliozzi, M; Ilari, S; Lauro, F; Malafoglia, V; Mollace, V; Muscoli, C; Palma, E; Russo, MA; Salvemini, D; Sansone, L; Tafani, M; Tomino, C | 1 |
| Cui, Y; Gou, X; Li, L; Li, Y; Mi, Y; Ning, J; Qiu, Z; Wang, X | 1 |
| Coronel, MF; González, SL; Miguel, CA; Noya-Riobó, MV; Recalde, MD; Villar, MJ | 1 |
| Cai, G; Huang, S; Huang, Y; Liu, W; Ren, S; Shi, Y; Wang, Y; Wu, W; Zeng, Y; Zhan, H | 1 |
| Wu, K; Xing, C; Xing, XL; Yao, Z; Zhang, T; Zhang, Z | 1 |
| Ishikawa, H; Okubo, N; Sano, R; Shimazu, Y; Takeda, M | 1 |
| Bahari, Z; Bahrami, F; Ghasemi, M; Hosseini, M; Iman, M; Mohammadi, MT; Zabihian, MA | 1 |
| Iwata, K; Kubota, Y; Shimazu, Y; Takeda, M; Takehana, S; Uotsu, N; Yui, K | 1 |
| Singh, AK; Vinayak, M | 2 |
| Asiedu, MN; Burton, MD; Dussor, G; Hughes, T; Inyang, K; Lian, B; Mazhar, K; Mejia, GL; Price, TJ; Tillu, DV | 1 |
| Constandil, L; Flores, C; Hernandez, A; Kogan, MJ; Lespay-Rebolledo, C; Lobos, N; Lux, S; Pelissier, T; Pinto, M; Salas-Huenuleo, E | 1 |
| Cao, L; Ge, M; Guo, R; Hu, L; Miao, C; Shao, Y; Yang, Y; Yin, Y | 1 |
| Cui, WG; Wang, C; Xu, Y; Ye, F; Yu, C; Zhang, JF; Zhao, X; Zhou, WH | 1 |
| Cheng, W; Fan, Q; Li, J; Liu, H; Lu, FF; Yan, CD; Yin, Q; Zhao, Y | 1 |
| Bica, CG; da Silva, VD; Dora, CL; Hadrich, G; Klein, CP; Lopes, TG; Morrone, FB; Nicoletti, NF; Schwingel, TE | 1 |
| Ding, W; Luo, Y; Shao, H; Xue, Q; Yu, B; Zhang, F; Zhang, H; Zhang, X; Zhu, H | 1 |
| Chen, Y; Guo, SW; Liu, X; Zhang, H; Zhu, B | 1 |
| Ding, Q; Gao, C; Sun, X; Tao, L | 1 |
| Chen, YY; Gu, HY; Hu, J; Shen, YL; Shi, DL; Song, XH; Wang, LL; Zheng, MZ | 1 |
| Hidaka, S; Inoue, M; Kanai, Y; Kubota, Y; Matsuzawa, N; Sekiguchi, K; Shibuya, E; Shimazu, Y; Takeda, M; Takehana, S | 1 |
| Hu, L; Jiang, CY; Miao, C; Wang, L; Xia, YP; Yang, CQ; Yang, YJ; Yuan, M | 1 |
| Fenning, AS; Irwin, JC; Phyu, HE; Vella, RK | 1 |
| Chen, YC; Wang, DP; Wang, ZM | 1 |
| Chen, YY; Shen, YL; Shi, DL; Song, XH; Wang, LL; Zhang, L; Zheng, MZ | 1 |
| Beloeil, H; Benhamou, D; Benoit, G; Gentili, M; Mazoit, JX; Pham-Marcou, TA; Sun, X; Yaici, D | 1 |
| Bertelli, A; Dib, B; Falchi, M; Galazzo, R; Viganò, P | 1 |
| Asiedu, MN; De Felice, M; Dussor, G; Melemedjian, OK; Price, TJ; Qu, N; Tillu, DV | 1 |
| Akude, E; Calcutt, NA; Fernyhough, P; Gomes, S; Marquez, A; Morrow, D; Roy Chowdhury, SK; Saleh, A; Schapansky, J; Smith, DR | 1 |
| Chopra, K; Kulkarni, SK; Sharma, S | 2 |
| Benhamou, D; Bouaziz, H; Casper, RF; Fletcher, D; Gentilli, M; Mazoit, JX; Savouret, JF | 1 |
36 other study(ies) available for resveratrol and Allodynia
| Article | Year |
|---|---|
Resveratrol Inhibition of the WNT/β-Catenin Pathway following Discogenic Low Back Pain.
Topics: Animals; beta Catenin; Humans; Hyperalgesia; Inflammation; Low Back Pain; Rats; Rats, Sprague-Dawley; Resveratrol; Wnt Signaling Pathway | 2022 |
Reduction of SIRT1-Mediated Epigenetic Upregulation of Nav1.7 Contributes to Oxaliplatin-Induced Neuropathic Pain.
Topics: Animals; Epigenesis, Genetic; Ganglia, Spinal; Histones; Hyperalgesia; Neuralgia; Oxaliplatin; Rats; Rats, Sprague-Dawley; Resveratrol; RNA, Small Interfering; Sirtuin 1; Up-Regulation | 2023 |
Analgesic effect of resveratrol on colitis-induced visceral pain via inhibition of TRAF6/NF-κB signaling pathway in the spinal cord.
Topics: Analgesics; Animals; Colitis; Glial Fibrillary Acidic Protein; Hyperalgesia; Male; Mice; Mice, Inbred C57BL; Neuralgia; NF-kappa B; Resveratrol; Signal Transduction; Spinal Cord; TNF Receptor-Associated Factor 6; Tumor Necrosis Factor-alpha; Visceral Pain | 2019 |
Resveratrol suppresses bone cancer pain in rats by attenuating inflammatory responses through the AMPK/Drp1 signaling.
Topics: AMP-Activated Protein Kinases; Animals; Astrocytes; Bone Neoplasms; Cancer Pain; Cell Line, Tumor; Dynamins; Female; Hyperalgesia; Inflammation; Mitochondria; Mitochondrial Dynamics; Osteosarcoma; Pain; Rats; Rats, Sprague-Dawley; Resveratrol; Signal Transduction; Spinal Cord | 2020 |
Antioxidant modulation of sirtuin 3 during acute inflammatory pain: The ROS control.
Topics: Analgesics; Animals; Antioxidants; Cell Line, Tumor; Humans; Hyperalgesia; Male; Metalloporphyrins; Oxidative Stress; Pain Threshold; Protein Carbonylation; Rats, Sprague-Dawley; Reactive Oxygen Species; Resveratrol; Signal Transduction; Sirtuins; Spinal Cord; Superoxide Dismutase | 2020 |
Resveratrol alleviates diabetic mechanical allodynia in rats by downregulating P2X3R.
Topics: Analgesics; Animals; Behavior, Animal; Diabetes Mellitus, Experimental; Down-Regulation; Drug Administration Routes; Ganglia, Spinal; Hyperalgesia; Male; Neurons; Rats; Rats, Sprague-Dawley; Receptors, Purinergic P2X3; Resveratrol; Spinal Cord Dorsal Horn; Stomach; Streptozocin | 2020 |
Resveratrol exerts anti-oxidant and anti-inflammatory actions and prevents oxaliplatin-induced mechanical and thermal allodynia.
Topics: Animals; Anti-Inflammatory Agents; Antioxidants; Cytokines; Ganglia, Spinal; Hyperalgesia; Male; Oxaliplatin; Oxidative Stress; Pain Measurement; Rats; Resveratrol; Sciatic Nerve; Spinal Cord | 2020 |
Resveratrol mediates mechanical allodynia through modulating inflammatory response via the TREM2-autophagy axis in SNI rat model.
Topics: Animals; Antioxidants; Autophagy; Disease Models, Animal; Hyperalgesia; Inflammation; Male; Membrane Glycoproteins; Posterior Horn Cells; Rats; Rats, Sprague-Dawley; Receptors, Immunologic; Resveratrol; Sural Nerve | 2020 |
Resveratrol rescued the pain related hypersensitivity for Cntnap2-deficient mice.
Topics: Analgesics; Animals; Disease Models, Animal; Hyperalgesia; Male; Membrane Proteins; Mice, Knockout; Nerve Tissue Proteins; Pain Threshold; Phosphorylation; Resveratrol; Ribosomal Protein S6; Signal Transduction; Spinal Cord; TOR Serine-Threonine Kinases | 2021 |
Effect of resveratrol on the hyperexcitability of nociceptive neurons associated with ectopic hyperalgesia induced by experimental tooth movement.
Topics: Animals; Hyperalgesia; Nociceptors; Rats; Rats, Wistar; Resveratrol; Trigeminal Nucleus, Spinal | 2020 |
Intracerebroventricular injection of propranolol blocked analgesic and neuroprotective effects of resveratrol following L
Topics: Analgesics; Animals; Disease Models, Animal; Hyperalgesia; Ligation; Male; Neuroprotective Agents; Propranolol; Rats; Rats, Sprague-Dawley; Rats, Wistar; Resveratrol; Spinal Nerves | 2021 |
The dietary constituent resveratrol suppresses nociceptive neurotransmission via the NMDA receptor.
Topics: Action Potentials; Animals; Dose-Response Relationship, Drug; Enzyme Inhibitors; Excitatory Amino Acid Agonists; Glutamic Acid; Hyperalgesia; Iontophoresis; Male; N-Methylaspartate; Rats; Rats, Wistar; Receptors, N-Methyl-D-Aspartate; Resveratrol; Sensory Receptor Cells; Stilbenes; Trigeminal Nucleus, Spinal | 2017 |
Resveratrol alleviates inflammatory hyperalgesia by modulation of reactive oxygen species (ROS), antioxidant enzymes and ERK activation.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Antioxidants; Freund's Adjuvant; Hyperalgesia; Inflammation; MAP Kinase Signaling System; Pain Measurement; Rats; Reactive Oxygen Species; Receptors, Tumor Necrosis Factor, Type I; Resveratrol; Stilbenes | 2017 |
Pharmacological activation of AMPK inhibits incision-evoked mechanical hypersensitivity and the development of hyperalgesic priming in mice.
Topics: AMP-Activated Protein Kinases; Analgesics; Animals; Cells, Cultured; Ganglia, Spinal; Hyperalgesia; Male; Metformin; Mice, Inbred ICR; Neurons; Pain; Pain Threshold; Postoperative Complications; Resveratrol; Signal Transduction; Stilbenes | 2017 |
The antinociceptive effect of resveratrol in bone cancer pain is inhibited by the Silent Information Regulator 1 inhibitor selisistat.
Topics: Analgesics; Animals; Behavior, Animal; Bone Neoplasms; Cancer Pain; Carbazoles; Cell Line, Tumor; Disease Models, Animal; Hyperalgesia; Male; Mice; Mice, Inbred BALB C; Resveratrol; Sirtuin 1 | 2019 |
Pretreatment with resveratrol ameliorate trigeminal neuralgia by suppressing matrix metalloproteinase-9/2 in trigeminal ganglion.
Topics: Animals; Anti-Inflammatory Agents; Hyperalgesia; Matrix Metalloproteinase 2; Matrix Metalloproteinase 9; Mice; Neuralgia; NF-kappa B; Resveratrol; Toll-Like Receptor 4; Trigeminal Ganglion; Trigeminal Neuralgia | 2019 |
Chronic resveratrol treatment exerts antihyperalgesic effect and corrects co-morbid depressive like behaviors in mice with mononeuropathy: involvement of serotonergic system.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Antidepressive Agents; Brain; Comorbidity; Constriction, Pathologic; Depression; Disease Models, Animal; Hot Temperature; Hyperalgesia; Male; Mice, Inbred C57BL; Neuralgia; Receptor, Serotonin, 5-HT1A; Receptors, Serotonin; Resveratrol; Sciatic Neuropathy; Spinal Cord; Stilbenes; Touch | 2014 |
Resveratrol attenuates bone cancer pain through the inhibition of spinal glial activation and CX3CR1 upregulation.
Topics: Analgesics; Animals; Bone Neoplasms; CX3C Chemokine Receptor 1; Hyperalgesia; Injections, Spinal; Neuroglia; Pain; Rats; Rats, Sprague-Dawley; Receptors, Chemokine; Resveratrol; Stilbenes; Up-Regulation | 2014 |
Effects of the compounds resveratrol, rutin, quercetin, and quercetin nanoemulsion on oxaliplatin-induced hepatotoxicity and neurotoxicity in mice.
Topics: Alanine Transaminase; Animals; Antineoplastic Agents; Aspartate Aminotransferases; Caspase 3; Emulsions; Fatty Liver; Hyperalgesia; Lumbar Vertebrae; Male; Mice, Inbred BALB C; Neurotoxicity Syndromes; Organoplatinum Compounds; Oxaliplatin; Peroxidase; Proto-Oncogene Proteins c-fos; Quercetin; Resveratrol; Rutin; Spinal Cord; Stilbenes | 2014 |
Spinal SIRT1 activation attenuates neuropathic pain in mice.
Topics: Animals; Down-Regulation; Hyperalgesia; Male; Mice; Mice, Inbred Strains; NAD; Neuralgia; Niacinamide; Resveratrol; Sirtuin 1; Spinal Cord; Stilbenes | 2014 |
Resveratrol Reduces Myometrial Infiltration, Uterine Hyperactivity, and Stress Levels and Alleviates Generalized Hyperalgesia in Mice With Induced Adenomyosis.
Topics: Adenomyosis; Animals; Animals, Newborn; Behavior, Animal; Cluster Analysis; Corticosterone; Disease Models, Animal; Dose-Response Relationship, Drug; Female; Glutamate Decarboxylase; Hyperalgesia; Mice, Inbred ICR; Myometrium; Nucleus Raphe Magnus; Pain Threshold; Phenotype; Reaction Time; Resveratrol; Stilbenes; Tamoxifen; Time Factors; Uterine Contraction; Uterus | 2015 |
Resveratrol attenuates neuropathic pain through balancing pro-inflammatory and anti-inflammatory cytokines release in mice.
Topics: Animals; Anti-Inflammatory Agents; Cells, Cultured; Cytokines; Disease Models, Animal; Female; Humans; Hyperalgesia; Mice; Mice, Inbred BALB C; Microglia; Neuralgia; Neurogenic Inflammation; Resveratrol; Sciatic Nerve; Stilbenes; Th1-Th2 Balance | 2016 |
Resveratrol attenuates inflammatory hyperalgesia by inhibiting glial activation in mice spinal cords.
Topics: Animals; Antigens, Differentiation; Dose-Response Relationship, Drug; Hyperalgesia; Lipopolysaccharides; Male; Mice; Mice, Inbred ICR; Neuroglia; Resveratrol; Spinal Cord; Stilbenes | 2016 |
Anti-Nociceptive Effect of Resveratrol During Inflammatory Hyperalgesia via Differential Regulation of pro-Inflammatory Mediators.
Topics: Analgesics; Animals; Cyclooxygenase 2; Cytokines; Hyperalgesia; Inflammation Mediators; Male; Nitric Oxide Synthase Type II; Rats; Resveratrol; Spinal Cord; Stilbenes | 2016 |
Resveratrol attenuates inflammation-induced hyperexcitability of trigeminal spinal nucleus caudalis neurons associated with hyperalgesia in rats.
Topics: Animals; Hyperalgesia; Inflammation; Male; Neurons; Rats, Wistar; Resveratrol; Stilbenes; Trigeminal Nucleus, Spinal | 2016 |
Resveratrol suppresses glial activation and alleviates trigeminal neuralgia via activation of AMPK.
Topics: AMP-Activated Protein Kinases; Animals; Anti-Inflammatory Agents; Blotting, Western; Disease Models, Animal; Enzyme Activation; Fluorescent Antibody Technique; Hyperalgesia; Male; Neuroglia; Rats; Rats, Sprague-Dawley; Resveratrol; Stilbenes; Trigeminal Neuralgia | 2016 |
Resveratrol shows neuronal and vascular-protective effects in older, obese, streptozotocin-induced diabetic rats.
Topics: Analgesics; Animals; Antioxidants; Cardiovascular Diseases; Diabetes Mellitus, Experimental; Endothelium, Vascular; Hyperalgesia; Male; Muscle Contraction; Nervous System; Obesity; Plant Extracts; Polyphenols; Random Allocation; Rats, Wistar; Resveratrol; Stilbenes | 2016 |
Resveratrol, a natural antioxidant, protects monosodium iodoacetate-induced osteoarthritic pain in rats.
Topics: Animals; Antioxidants; Cartilage, Articular; Cyclooxygenase 2; Cytokines; Extremities; Hyperalgesia; Iodoacetates; Male; Nitric Oxide Synthase Type II; Osteoarthritis; Pain; Rats, Sprague-Dawley; Resveratrol; RNA, Messenger; Stilbenes; Synovial Fluid | 2016 |
Resveratrol Attenuates Subacute Systemic Inflammation-Induced Spatial Memory Impairment via Inhibition of Astrocyte Activation and Enhancement of Synaptophysin Expression in the Hippocampus.
Topics: Animals; Astrocytes; Blotting, Western; Glial Fibrillary Acidic Protein; Hippocampus; Hyperalgesia; Immunohistochemistry; Inflammation; Lipopolysaccharides; Male; Maze Learning; Memory Disorders; Mice, Inbred ICR; Microglia; Models, Biological; Resveratrol; Sirtuin 1; Spatial Memory; Stilbenes; Synaptophysin | 2017 |
Antinociceptive effect of resveratrol in carrageenan-evoked hyperalgesia in rats: prolonged effect related to COX-2 expression impairment.
Topics: Analgesics; Animals; Anti-Inflammatory Agents, Non-Steroidal; Carrageenan; Cyclooxygenase 2; Dose-Response Relationship, Drug; Down-Regulation; Hyperalgesia; Male; Pain Threshold; Rats; Rats, Sprague-Dawley; Resveratrol; Stilbenes; Touch | 2008 |
Central antalgic activity of resveratrol.
Topics: Analgesics; Animals; Disease Models, Animal; Hyperalgesia; Injections, Intraventricular; Male; Motor Activity; Pain Measurement; Physical Stimulation; Rats; Rats, Wistar; Reaction Time; Resveratrol; Stilbenes | 2010 |
Resveratrol engages AMPK to attenuate ERK and mTOR signaling in sensory neurons and inhibits incision-induced acute and chronic pain.
Topics: Acute Pain; AMP-Activated Protein Kinases; Animals; Chronic Pain; Disease Models, Animal; Dose-Response Relationship, Drug; Eukaryotic Initiation Factor-4F; Extracellular Signal-Regulated MAP Kinases; Hyperalgesia; Interleukin-6; Male; Mice; Mice, Inbred ICR; Pain, Postoperative; Protein Biosynthesis; Resveratrol; Sensory Receptor Cells; Signal Transduction; Sirtuin 1; Stilbenes; Time Factors; TOR Serine-Threonine Kinases; Trigeminal Ganglion | 2012 |
Impaired adenosine monophosphate-activated protein kinase signalling in dorsal root ganglia neurons is linked to mitochondrial dysfunction and peripheral neuropathy in diabetes.
Topics: Adenosine Triphosphate; AMP-Activated Protein Kinases; Analysis of Variance; Animals; Anti-Inflammatory Agents, Non-Steroidal; Blood Glucose; Body Weight; Cells, Cultured; Diabetes Mellitus, Experimental; Disease Models, Animal; Dose-Response Relationship, Drug; Ganglia, Spinal; Gene Expression Regulation; Green Fluorescent Proteins; Hyperalgesia; Male; Membrane Potentials; Mice; Mitochondrial Diseases; Mitochondrial Membranes; Mutation; Nerve Fibers, Myelinated; Neurites; Oxygen Consumption; Patch-Clamp Techniques; Peripheral Nervous System Diseases; Peroxisome Proliferator-Activated Receptor Gamma Coactivator 1-alpha; Physical Stimulation; Rats; Rats, Sprague-Dawley; Reaction Time; Resveratrol; RNA-Binding Proteins; Sensory Receptor Cells; Signal Transduction; Stilbenes; Transcription Factors; Transduction, Genetic | 2012 |
Resveratrol, a polyphenolic phytoalexin attenuates thermal hyperalgesia and cold allodynia in STZ-induced diabetic rats.
Topics: Animals; Antioxidants; Blood Glucose; Body Weight; Cold Temperature; Diabetes Mellitus, Experimental; Hot Temperature; Hyperalgesia; Immersion; Male; Phytoalexins; Plant Extracts; Rats; Rats, Sprague-Dawley; Resveratrol; Sesquiterpenes; Stilbenes; Terpenes | 2006 |
Effect of resveratrol, a polyphenolic phytoalexin, on thermal hyperalgesia in a mouse model of diabetic neuropathic pain.
Topics: Analgesics, Non-Narcotic; Animals; Brain; Diabetes Mellitus, Experimental; Hot Temperature; Hyperalgesia; Male; Mice; Mice, Inbred Strains; Neuralgia; Nitric Oxide; Pain Threshold; Phytoalexins; Resveratrol; Sesquiterpenes; Stilbenes; Terpenes; Tumor Necrosis Factor-alpha | 2007 |
Resveratrol decreases hyperalgesia induced by carrageenan in the rat hind paw.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Carrageenan; Cyclooxygenase 2; Cyclooxygenase 2 Inhibitors; Cyclooxygenase Inhibitors; Edema; Foot; Hindlimb; Hyperalgesia; Isoenzymes; Kinetics; Male; Pain Measurement; Prostaglandin-Endoperoxide Synthases; Rats; Rats, Sprague-Dawley; Receptors, Aryl Hydrocarbon; Resveratrol; Stilbenes; Vocalization, Animal | 2001 |